Frequently Asked Questions
The market is segmented based on , By Device Type (Conventional Device, Advanced Device), End User (Hospitals, Clinics, Cardiac Catheterization Laboratories, Ambulatory Surgical Centres, Others) - Industry Trends and Forecast to 2030.
.
The Global Interventional Cardiology Market size was valued at USD 14.61 USD Billion in 2022.
The Global Interventional Cardiology Market is projected to grow at a CAGR of 7.1% during the forecast period of 2023 to 2030.
The major players operating in the market include ABIOMED , ACIST Medical Systems, B Braun Melsungen AG, Biotronik SE & Co KG, Boston Scientific Corporation, BD, Cook, Cardinal Health, Edwards Lifesciences Corporation, Ivascular, Johnson & Johnson Services , Medtronic, Merit Medical Systems, Koninklijke Philips NV, Abbott, Terumo Corporation, Rontis Corporation, W L Gore & Associates , Biosensors International Group Ltd, GENERAL ELECTRIC COMPANY.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, and Rest of Middle East and Africa.
